30. November 2016
Press Release: Zedira receives funding by the German Government for the development of transglutaminase inhibitors for the treatment of diabetic nephropathy
Read more | Document
30. November 2016
Pressemitteilung: Zedira erhält Fördermittel für die Entwicklung von Transglutaminase-Blockern zur Behandlung der diabetischen Nephropathie
Read more | Document
22. September 2016
Zedira supports 2nd International Factor XIII Workshop
Read more | Document
1. July 2016
Press Release: Dr. Falk Pharma GmbH and Zedira enter a phase 1b clinical trial for a celiac disease drug
Read more | Document
1. July 2016
Pressemitteilung: Dr. Falk Pharma GmbH und Zedira GmbH starten klinische Phase 1b zur medikamentoesen Behandlung der Zöliakie
Read more | Document
23. May 2016
Zedira publication: Microbial transglutaminase has a lower deamidation preference than human tissue transglutaminase on a celiac disease relevant wheat gliadin T-cell epitope
Read more | Document
20. April 2016
Zöliakie weit mehr als ein bisschen Bauchschmerzen und Durchfall Von der Grundlagenforschung zur klinischen Entwicklung
Read more | Document
25. February 2016
Curious about your antibody or anti-serum?
Read more | Document
26. January 2016
Zedira supports Gordon Research Conference on "Transglutaminases in Human Disease Processes"
Read more | Document

News

Blog

Events